BioMedical Engineering Conference 2025
At BioMedical Engineering Conference 2025 held in Glasgow on Sept 4th to 5th, I presented my poster on whether Mismatch Negativity (MMN) is a marker of central neuropathic pain Intensity in Spinal Cord Injury (SCI) - these are results from a home-based pilot study. Abstract : Cross-sectional studies have shown that pain affects brain activity in Central Neuropathic Pain. However, more studies are needed to establish if mismatch negativity (MMN) is a biomarker for pain intensity. This work aims to determine whether the changes in MMN, i.e., amplitude and latency, is predictive of change in central neuropathic pain intensity due to medication. In this longitudinal study, ten people with spinal cord injury-related central neuropathic pain recorded their response to MMN experiment using home-based self-guided EEG set-up for ten days both before and after taking medications over a period of several weeks. We found that the change in MMN was not predictive of change in central neur...